查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1467570

2024-2032 年精準精神科市場報告（按產品類型、樣本、生物標記類型、技術、應用、最終用戶和地區）

Precision Psychiatry Market Report by Product Type, Sample, Biomarker Type, Technology, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年全球精準精神醫學市場規模達10.597億美元。大眾心理健康疾病的盛行率不斷上升，對個人化治療計畫和介入措施的需求不斷成長，以及基因檢測和資料分析的出現，是推動市場發展的一些關鍵因素。

精準精神醫學是指廣泛應用於精神健康保健的創新醫療方法。它利用眾多先進技術和個人化醫療，為患有精神疾病的個人提供更有針對性和更有效的治療。它認知到精神疾病，如憂鬱症、焦慮症、躁鬱症和精神分裂症，是複雜且多方面的疾病，受到遺傳、環境和生活方式因素的綜合影響。它的目的是根據個人的獨特特徵（包括基因組成、神經生物學標記和個人情況）客製化多種干預措施。它使臨床醫生能夠更深入地了解精神疾病的潛在機制，並相應地制定個人化的治療計劃。除此之外，它還識別出可能導致對某些心理健康狀況的易感性或影響對特定藥物的反應的特定遺傳變異。這些資訊允許選擇更合適和更有針對性的治療方案，增加積極結果的可能性，同時最大限度地減少潛在的不利影響。

精準精神醫學市場趨勢：

全球市場的主要驅動力是大眾心理健康疾病盛行率的上升。加上對個人化治療計劃和干涉措施的需求不斷成長，個人對精準精神病學的採用大幅增加。由於精準精神醫學符合各醫學領域個人化醫療的更廣泛趨勢。它認知到每個人都是獨一無二的，需要根據其遺傳、神經生物學和環境因素進行客製化治療。這種個人化的方法引起了患者的共鳴，因為它提供了更有效的治療和改善的結果的前景，這在大眾中獲得了廣泛的關注。此外，不斷的技術進步，例如基因檢測、神經影像和資料分析的出現，極大地促進了精準精神病學的發展和實施，進一步對市場產生了有利的影響。除此之外，人們對精準精神醫學的興趣日益濃厚，研究活動和資金支持也不斷增加。學術機構、研究組織和製藥公司正在投資研究，以更好地了解精神疾病的生物學機制並開發有針對性的治療方法，從而為市場提供動力。其他因素，包括快速城市化、個人意識的增強以及醫療基礎設施的持續發展，也對市場產生積極影響。

本報告回答的關鍵問題：

  • 迄今為止，全球精準精神醫學市場表現如何，未來幾年將如何表現？
  • 全球精準精神醫學市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球精準精神科市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的精準精神醫學市場？
  • 依產品類型分類的市場是怎麼樣的？
  • 精準精神科市場中最具吸引力的產品類型是什麼？
  • 根據樣本，市場的詳細情形如何？
  • 精準精神醫學市場上最具吸引力的樣本是什麼？
  • 基於生物標誌類型的市場區隔是什麼？
  • 精準精神科市場中最具吸引力的生物標記類型是什麼？
  • 什麼是基於技術的市場分割？
  • 精準精神醫學市場中哪一項技術最具吸引力？
  • 基於應用程式的市場區隔是什麼？
  • 精準精神醫學市場中最具吸引力的應用是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 哪個是精準精神醫學市場中最具吸引力的最終使用者？
  • 全球精準精神醫學市場的競爭結構如何？
  • 全球精準精神科市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球精準精神醫學市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品類型

  • 產品
    • 市場走向
    • 市場預測
  • 服務
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依樣本

  • 血液為基礎
    • 市場走向
    • 市場預測
  • 非血液基礎
    • 市場走向
    • 關鍵環節
      • 唾液
      • 尿
      • 腦脊髓液 (CSF)
      • 其他
    • 市場預測

第 8 章：市場細分：依生物標記類型

  • 基因生物標記
    • 市場走向
    • 市場預測
  • 蛋白質生物標記
    • 市場走向
    • 市場預測

第 9 章：市場區隔：依技術

  • 定序
    • 市場走向
    • 關鍵環節
      • 新一代定序 (NGS)
      • 桑格定序
    • 市場預測
  • 聚合酶鍊式反應 (PCR)
    • 市場走向
    • 關鍵環節
      • 即時聚合酶鍊式反應 (RT-PCR)
      • 數位聚合酶鍊式反應 (dPCR)
    • 市場預測
  • 微陣列
    • 市場走向
    • 市場預測
  • 免疫分析
    • 市場走向
    • 市場預測
  • 液相層析質譜聯用 (LC-MS)
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章：市場區隔：按應用

  • 阿茲海默氏症
    • 市場走向
    • 市場預測
  • 帕金森氏症
    • 市場走向
    • 市場預測
  • 自閉症
    • 市場走向
    • 市場預測
  • 沮喪
    • 市場走向
    • 市場預測
  • 雙極性情感障礙
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 11 章：市場區隔：依最終用戶

  • 醫院和診斷實驗室
    • 市場走向
    • 市場預測
  • 學術研究機構
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 12 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 13 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 14 章：價值鏈分析

第 15 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 16 章：價格分析

第17章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Altimate Healthcare
    • Alto Nanoscience
    • ATAI Life Sciences NV
    • Fulgent Genetics Inc.
    • Invitae Corporation
    • Myriad Genetics Inc.
    • Precision Psychiatric Services Inc.
    • Tempus Labs Inc.
Product Code: SR112024A13298

The global precision psychiatry market size reached US$ 1,059.7 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 4,027.9 Million by 2032, exhibiting a growth rate (CAGR) of 15.5% during 2024-2032. The rising prevalence of mental health disorders among the masses, the growing need for personalized treatment plans and interventions and the advent of genetic testing, and data analytics represent some of the key factors driving the market.

Precision psychiatry refers to an innovative medical approach that is widely adopted for mental health care. It leverages numerous advanced technologies and personalized medicine to provide more targeted and effective treatments for individuals suffering from psychiatric disorders. It recognizes that mental illnesses, such as depression, anxiety, bipolar disorder, and schizophrenia, are complex and multifaceted conditions influenced by a combination of genetic, environmental, and lifestyle factors. It aims to tailor multiple interventions based on an individual's unique characteristics, including their genetic makeup, neurobiological markers, and personal circumstances. It allows clinicians to gain deeper insights into the underlying mechanisms of psychiatric disorders and develop personalized treatment plans accordingly. Besides this, it also identifies specific genetic variations that may contribute to the susceptibility to certain mental health conditions or influence the response to particular medications. This information allows for the selection of more appropriate and targeted treatment options, increasing the likelihood of positive outcomes while minimizing the potential for adverse effects.

Precision Psychiatry Market Trends:

The global market is majorly driven by the rising prevalence of mental health disorders among the masses. Coupled with the growing need for personalized treatment plans and interventions, there has been a considerable increase in the adoption of precision psychiatry among individuals. Since precision psychiatry aligns with the broader trend toward personalized medicine across various medical fields. It recognizes that each individual is unique and requires tailored treatments based on their genetic, neurobiological, and environmental factors. This personalized approach resonates with patients, as it offers the prospect of more effective treatments and improved outcomes, which is gaining widespread prominence among the masses. Moreover, continual technological advancements, such as the advent of genetic testing, neuroimaging, and data analytics have significantly contributed to the development and implementation of precision psychiatry, further impacting the market favorably. Apart from this, the growing interest in precision psychiatry is accompanied by rising research activities and funding support. Academic institutions, research organizations, and pharmaceutical companies are investing in research to better understand the biological mechanisms of psychiatric disorders and develop targeted treatments, hence providing an impetus to the market. Other factors, including rapid urbanization, growing awareness among individuals and continual developments in the healthcare infrastructure, are also positively influencing the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global precision psychiatry market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type, sample, biomarker type, technology, application, and end user.

Product Type Insights:

Products

Services

The report has provided a detailed breakup and analysis of the precision psychiatry market based on the product type. This includes products and services. According to the report, products represented the largest segment.

Sample Insights:

Blood-Based

Non-Blood-Based

Saliva

Urine

Cerebral Spinal Fluid (CSF)

Others

A detailed breakup and analysis of the precision psychiatry market based on the sample has also been provided in the report. This includes blood-based and non-blood-based (saliva, urine, cerebral spinal fluid (CSF), and others). According to the report, non-blood-based accounted for the largest market share.

Biomarker Type Insights:

Genetic Biomarker

Protein Biomarker

The report has provided a detailed breakup and analysis of the precision psychiatry market based on the biomarker type. This includes genetic biomarker and protein biomarker. According to the report, protein biomarker exhibits a clear dominance in the market.

Technology Insights:

Sequencing

Next-Generation Sequencing (NGS)

Sanger Sequencing

Polymerase Chain Reaction (PCR)

Real-Time Polymerase Chain Reaction (RT-PCR)

Digital Polymerase Chain Reaction (dPCR)

Microarray

Immunoassay

Liquid Chromatography-Mass Spectrometry (LC-MS)

Others

The report has provided a detailed breakup and analysis of the precision psychiatry market based on the technology. This includes sequencing [next-generation sequencing (NGS) and sanger sequencing], polymerase chain reaction (PCR) [real-time polymerase chain reaction (RT-PCR) and digital polymerase chain reaction (dPCR)], microarray, immunoassay, liquid chromatography-mass spectrometry (LC-MS), and others. According to the report, sequencing represented the largest segment.

Application Insights:

Alzheimer's Disease

Parkinson's Disease

Autism

Depression

Bipolar Disease

Others

A detailed breakup and analysis of the precision psychiatry market based on the application has also been provided in the report. This includes Alzheimer's disease, Parkinson's disease, autism, depression, bipolar disease, and others. According to the report, depression accounted for the largest market share.

End User Insights:

Hospitals and Diagnostic Laboratories

Academic and Research Institutions

Others

The report has provided a detailed breakup and analysis of the precision psychiatry market based on the end user. This includes hospitals and diagnostic laboratories, academic and research institutions and others. According to the report, hospitals and diagnostic laboratories exhibits a clear dominance in the market.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for precision psychiatry. Some of the factors driving the North America precision psychiatry market included the growing awareness among the masses, the emerging healthcare industry, the shifting lifestyle preferences of the masses, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global precision psychiatry market. Detailed profiles of all major companies have been provided. Some of the companies covered include Altimate Healthcare, Alto Nanoscience, ATAI Life Sciences N.V., Fulgent Genetics Inc, Invitae Corporation, Myriad Genetics Inc., Precision Psychiatric Services Inc., Tempus Labs Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global precision psychiatry market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global precision psychiatry market?
  • What is the impact of each driver, restraint, and opportunity on the global precision psychiatry market?
  • What are the key regional markets?
  • Which countries represent the most attractive precision psychiatry market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the precision psychiatry market?
  • What is the breakup of the market based on the sample?
  • Which is the most attractive sample in the precision psychiatry market?
  • What is the breakup of the market based on the biomarker type?
  • Which is the most attractive biomarker type in the precision psychiatry market?
  • What is the breakup of the market based on technology?
  • Which is the most attractive technology in the precision psychiatry market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the precision psychiatry market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the precision psychiatry market?
  • What is the competitive structure of the global precision psychiatry market?
  • Who are the key players/companies in the global precision psychiatry market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Precision Psychiatry Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Sample

  • 7.1 Blood-Based
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Non-Blood-Based
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Saliva
      • 7.2.2.2 Urine
      • 7.2.2.3 Cerebral Spinal Fluid (CSF)
      • 7.2.2.4 Others
    • 7.2.3 Market Forecast

8 Market Breakup by Biomarker Type

  • 8.1 Genetic Biomarker
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Protein Biomarker
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Technology

  • 9.1 Sequencing
    • 9.1.1 Market Trends
    • 9.2.2 Key Segments
      • 9.2.2.1 Next-Generation Sequencing (NGS)
      • 9.2.2.2 Sanger Sequencing
    • 9.1.3 Market Forecast
  • 9.2 Polymerase Chain Reaction (PCR)
    • 9.2.1 Market Trends
    • 9.2.2 Key Segments
      • 9.2.2.1 Real-Time Polymerase Chain Reaction (RT-PCR)
      • 9.2.2.2 Digital Polymerase Chain Reaction (dPCR)
    • 9.2.3 Market Forecast
  • 9.3 Microarray
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Immunoassay
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Liquid Chromatography-Mass Spectrometry (LC-MS)
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 Others
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Alzheimer's Disease
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Parkinson's Disease
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Autism
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Depression
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Bipolar Disease
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast
  • 10.6 Others
    • 10.6.1 Market Trends
    • 10.6.2 Market Forecast

11 Market Breakup by End User

  • 11.1 Hospitals and Diagnostic Laboratories
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Academic and Research Institutions
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Others
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 United States
      • 12.1.1.1 Market Trends
      • 12.1.1.2 Market Forecast
    • 12.1.2 Canada
      • 12.1.2.1 Market Trends
      • 12.1.2.2 Market Forecast
  • 12.2 Asia-Pacific
    • 12.2.1 China
      • 12.2.1.1 Market Trends
      • 12.2.1.2 Market Forecast
    • 12.2.2 Japan
      • 12.2.2.1 Market Trends
      • 12.2.2.2 Market Forecast
    • 12.2.3 India
      • 12.2.3.1 Market Trends
      • 12.2.3.2 Market Forecast
    • 12.2.4 South Korea
      • 12.2.4.1 Market Trends
      • 12.2.4.2 Market Forecast
    • 12.2.5 Australia
      • 12.2.5.1 Market Trends
      • 12.2.5.2 Market Forecast
    • 12.2.6 Indonesia
      • 12.2.6.1 Market Trends
      • 12.2.6.2 Market Forecast
    • 12.2.7 Others
      • 12.2.7.1 Market Trends
      • 12.2.7.2 Market Forecast
  • 12.3 Europe
    • 12.3.1 Germany
      • 12.3.1.1 Market Trends
      • 12.3.1.2 Market Forecast
    • 12.3.2 France
      • 12.3.2.1 Market Trends
      • 12.3.2.2 Market Forecast
    • 12.3.3 United Kingdom
      • 12.3.3.1 Market Trends
      • 12.3.3.2 Market Forecast
    • 12.3.4 Italy
      • 12.3.4.1 Market Trends
      • 12.3.4.2 Market Forecast
    • 12.3.5 Spain
      • 12.3.5.1 Market Trends
      • 12.3.5.2 Market Forecast
    • 12.3.6 Russia
      • 12.3.6.1 Market Trends
      • 12.3.6.2 Market Forecast
    • 12.3.7 Others
      • 12.3.7.1 Market Trends
      • 12.3.7.2 Market Forecast
  • 12.4 Latin America
    • 12.4.1 Brazil
      • 12.4.1.1 Market Trends
      • 12.4.1.2 Market Forecast
    • 12.4.2 Mexico
      • 12.4.2.1 Market Trends
      • 12.4.2.2 Market Forecast
    • 12.4.3 Others
      • 12.4.3.1 Market Trends
      • 12.4.3.2 Market Forecast
  • 12.5 Middle East and Africa
    • 12.5.1 Market Trends
    • 12.5.2 Market Breakup by Country
    • 12.5.3 Market Forecast

13 Drivers, Restraints, and Opportunities

  • 13.1 Overview
  • 13.2 Drivers
  • 13.3 Restraints
  • 13.4 Opportunities

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Price Analysis

17 Competitive Landscape

  • 17.1 Market Structure
  • 17.2 Key Players
  • 17.3 Profiles of Key Players
    • 17.3.1 Altimate Healthcare
      • 17.3.1.1 Company Overview
      • 17.3.1.2 Product Portfolio
    • 17.3.2 Alto Nanoscience
      • 17.3.2.1 Company Overview
      • 17.3.2.2 Product Portfolio
    • 17.3.3 ATAI Life Sciences N.V.
      • 17.3.3.1 Company Overview
      • 17.3.3.2 Product Portfolio
    • 17.3.4 Fulgent Genetics Inc.
      • 17.3.4.1 Company Overview
      • 17.3.4.2 Product Portfolio
    • 17.3.5 Invitae Corporation
      • 17.3.5.1 Company Overview
      • 17.3.5.2 Product Portfolio
    • 17.3.6 Myriad Genetics Inc.
      • 17.3.6.1 Company Overview
      • 17.3.6.2 Product Portfolio
    • 17.3.7 Precision Psychiatric Services Inc.
      • 17.3.7.1 Company Overview
      • 17.3.7.2 Product Portfolio
    • 17.3.8 Tempus Labs Inc.
      • 17.3.8.1 Company Overview
      • 17.3.8.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Precision Psychiatry Market: Major Drivers and Challenges
  • Figure 2: Global: Precision Psychiatry Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Precision Psychiatry Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Precision Psychiatry Market: Breakup by Sample (in %), 2023
  • Figure 6: Global: Precision Psychiatry Market: Breakup by Biomarker Type (in %), 2023
  • Figure 7: Global: Precision Psychiatry Market: Breakup by Technology (in %), 2023
  • Figure 8: Global: Precision Psychiatry Market: Breakup by Application (in %), 2023
  • Figure 9: Global: Precision Psychiatry Market: Breakup by End User (in %), 2023
  • Figure 10: Global: Precision Psychiatry Market: Breakup by Region (in %), 2023
  • Figure 11: Global: Precision Psychiatry (Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Precision Psychiatry (Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Precision Psychiatry (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Precision Psychiatry (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Precision Psychiatry (Blood-Based) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Precision Psychiatry (Blood-Based) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Precision Psychiatry (Non-Blood-Based) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Precision Psychiatry (Non-Blood-Based) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Precision Psychiatry (Genetic Biomarker) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Precision Psychiatry (Genetic Biomarker) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Precision Psychiatry (Protein Biomarker) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Precision Psychiatry (Protein Biomarker) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Precision Psychiatry (Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Precision Psychiatry (Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Precision Psychiatry (Polymerase Chain Reaction (PCR)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Precision Psychiatry (Polymerase Chain Reaction (PCR)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Precision Psychiatry (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Precision Psychiatry (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Precision Psychiatry (Immunoassay) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Precision Psychiatry (Immunoassay) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Precision Psychiatry (Liquid Chromatography-Mass Spectrometry (LC-MS)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Precision Psychiatry (Liquid Chromatography-Mass Spectrometry (LC-MS)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Precision Psychiatry (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Precision Psychiatry (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Precision Psychiatry (Alzheimer's Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Precision Psychiatry (Alzheimer's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Precision Psychiatry (Parkinson's Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Precision Psychiatry (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Precision Psychiatry (Autism) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Precision Psychiatry (Autism) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Precision Psychiatry (Depression) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Precision Psychiatry (Depression) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Precision Psychiatry (Bipolar Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Precision Psychiatry (Bipolar Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Global: Precision Psychiatry (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Global: Precision Psychiatry (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Global: Precision Psychiatry (Hospitals and Diagnostic Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Global: Precision Psychiatry (Hospitals and Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Global: Precision Psychiatry (Academic and Research Institutions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Global: Precision Psychiatry (Academic and Research Institutions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Global: Precision Psychiatry (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Global: Precision Psychiatry (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: North America: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: North America: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: United States: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: United States: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Canada: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Canada: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Asia-Pacific: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Asia-Pacific: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: China: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: China: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Japan: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Japan: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: India: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: India: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: South Korea: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: South Korea: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Australia: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Australia: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Indonesia: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Indonesia: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Europe: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Europe: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Germany: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Germany: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: France: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: France: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: United Kingdom: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: United Kingdom: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Italy: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Italy: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Spain: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Spain: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Russia: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Russia: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Others: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Others: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Latin America: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Latin America: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Brazil: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 94: Brazil: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 95: Mexico: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 96: Mexico: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 97: Others: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 98: Others: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 99: Middle East and Africa: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 100: Middle East and Africa: Precision Psychiatry Market: Breakup by Country (in %), 2023
  • Figure 101: Middle East and Africa: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 102: Global: Precision Psychiatry Industry: Drivers, Restraints, and Opportunities
  • Figure 103: Global: Precision Psychiatry Industry: Value Chain Analysis
  • Figure 104: Global: Precision Psychiatry Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Precision Psychiatry Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Precision Psychiatry Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Precision Psychiatry Market Forecast: Breakup by Sample (in Million US$), 2024-2032
  • Table 4: Global: Precision Psychiatry Market Forecast: Breakup by Biomarker Type (in Million US$), 2024-2032
  • Table 5: Global: Precision Psychiatry Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 6: Global: Precision Psychiatry Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 7: Global: Precision Psychiatry Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 8: Global: Precision Psychiatry Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 9: Global: Precision Psychiatry Market: Competitive Structure
  • Table 10: Global: Precision Psychiatry Market: Key Players